<scp>Y181C</scp> ‐associated virologic failure during long‐acting injectable cabotegravir/Rilpivirine in a patient engaged in intensive intravenous Chemsex
This case highlights that unexpected resistance can emerge during adequately administered LA-CAB/RPV therapy. Careful clinical evaluation is warranted when virologic failure occurs, particularly in the presence of extreme behavioural or physiological stressors.
Authors
- Santiago Melón
- Victor Asensi
- Rebeca Cabo
- María Rivas‐Carmenado
Institutions
- Hospital Universitario Central de Asturias (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
Publication Details
- Journal
- HIV Medicine
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1111/hiv.70199
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00